Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation.
These studies examined the receptors involved in angiotensin II (Ang II) stimulated secretion of systemic oxytocin (OT) and the role of this peptide in release of OT during suckling. Plasma OT concentrations were measured following intracerebroventricular (icv) injection of vehicle, Ang II, or Ang II following pretreatment with a selective AT1 (Losartan) or AT2 (PD 123319) receptor antagonist. Furthermore, we measured Ang II-induced OT release during central alpha-adrenergic receptor blockade (phentolamine). Finally, plasma OT concentrations before and during suckling were evaluated following central administration of Ang II receptor antagonists. The increase in systemic OT following central Ang II was abolished by AT1 receptor blockade and inhibited by the AT2 receptor antagonist. Furthermore, pretreatment with phentolamine significantly diminished systemic OT release in response to icv Ang II. Finally, central Ang II receptor blockade did not alter the increase in circulating OT during suckling. These data demonstrate that Ang II evoked OT release is mediated through activation of both AT1 and AT2 receptors and suggest that a component of Ang II-induced OT stimulation is due to norepinephrine release. Furthermore, central angiotensin systems do not have a direct role in stimulating OT release during suckling.
Bealer
Steven L
SL
Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, 30 South 2000 East Rm 201, Salt Lake City, UT 84112, USA.
Crowley
William R
WR
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000833:Animals, Suckling; D005260:Female; D007093:Imidazoles / Q000494:pharmacology; D007276:Injections, Intraventricular; D007774:Lactation / Q000097:blood / Q000187:drug effects / Q000378:metabolism*; D019808:Losartan / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010121:Oxytocin / Q000097:blood / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D020542:Third Ventricle
D000317:Adrenergic alpha-Antagonists; D057911:Angiotensin Receptor Antagonists; D007093:Imidazoles; D011725:Pyridines; D000804:Angiotensin II; C073402:PD 123319; D010121:Oxytocin; D019808:Losartan; D009638:Norepinephrine; D010646:Phentolamine